Prolacta Bioscience has announced the journal Cell Host & Microbe has published a proof-of-concept study evaluating the unique relationship between human milk oligosaccharides (HMOs) and the infant gut microbe Bifidobacterium longum subspecies infantis...
Human milk oligosaccharides (HMOs) — important groups of carbohydrates in human breast milk — can, in some cases, be secreted in very high concentrations, and still be safe and well-tolerated by infants.
On this week’s podcast, we have three conversations: with Ian Smith, sales director at PFF; Dr Ardythe Morrow, Professor of Epidemiology and Pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical...
Adventa Bioscience, a company dedicated to improving adult human health, has announced the launch of Trulacta, the world's first and only supplement made entirely of human milk.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Abbott has launched Similac Pro-Advance with a 2'-Fucosyllactose Oligosaccharide (2'-FL) not derived from breast milk, making it the first product in Canada with the ingredient in infant formula.
